Physician profile
Daniel Porter Barnes
NPI 1861429052
$6,619.96
in general payments reported to CMS, 2019-2025
45 companies · $1,082 in 2025
The $1,082 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $756 · 2020: $596 · 2021: $1,133 · 2022: $1,066 · 2023: $995 · 2024: $992 · 2025: $1,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,045 · Education: $23.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,044.77 |
| Education | $23.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,461.51 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Abbvie INC. | $1,403.05 | 2019-2025 | Lupron Depot, Botox |
| Pfizer INC. | $718.68 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $253.95 | 2020-2024 | Prolaris |
| Sumitomo Pharma America, INC. | $243.33 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $229.24 | 2022-2025 | Erleada |
| Blue Earth Diagnostics | $194.64 | 2019-2025 | Posluma |
| Merck Sharp & Dohme LLC | $191.15 | 2022-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Myovant Sciences INC. | $166.03 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $162.87 | 2020-2023 | Xiaflex |
| Antares Pharma, INC. | $154.62 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Verity Pharmaceuticals INC. | $154.42 | 2024-2025 | Trelstar |
| Boston Scientific Corporation | $134.50 | 2019-2024 | Rezum Generator, Spaceoar Vue System - 10ml |
| Dendreon Pharmaceuticals LLC | $99.43 | 2019-2025 | Provenge |
| Travere Therapeutics, INC. | $77.69 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.